cci 103f has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, PS; Franko, AJ; Kelly, DA; Raleigh, JA; Trimble, LA | 1 |
| Franko, AJ; Fuciarelli, AF; Kelly, DA; Koch, CJ; Miller, GG; Raleigh, JA | 1 |
2 other study(ies) available for cci 103f and Carcinoma 256, Walker
| Article | Year |
|---|---|
Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors.
Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Cell Hypoxia; Female; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tritium | 1991 |
Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.
Topics: Animals; Carcinoma 256, Walker; Female; Immunohistochemistry; Male; Microscopy, Fluorescence; Misonidazole; Nitroimidazoles; Oxygen; Rabbits; Tumor Cells, Cultured | 1987 |